REGULATORY
Drug Price Survey Sheets to Be Distributed with No Prefectural Govts In-Between: Chuikyo
The Ministry of Health, Labor and Welfare (MHLW) will directly distribute and collect survey sheets to and from wholesalers in conducting drug price surveys for regular biennial price revisions without the involvement of prefectural governments as go-betweens to increase efficiency.…
To read the full story
Related Article
- Chuikyo OKs Plan for FY2017 Drug Price Survey
June 14, 2017
REGULATORY
- MHLW Issues Q&A on Conditional Approval System
May 1, 2026
- Panel Backs Proposal to Allow Antibody Drugs Like Beyfortus in NIP
May 1, 2026
- METI Clarifies Naphtha Comments, Reaffirms Medical Priority
April 30, 2026
- Japan Minister Rules Out Full Self-Pay for OTC-Like Drugs
April 30, 2026
- Govt’s Bio-WG Wraps Up Biopharma Investment Roadmap Draft
April 30, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…





